Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

After Medical Errors, Patients Want Doctors to Hear Them Out

Lisa Rapaport  |  October 16, 2017

(Reuters Health)—When medical errors lead to serious injuries, patients and families may feel better when doctors take the time to listen to their feelings about the mistake and explain what can be done to prevent it from happening again, a small study suggests. The research team interviewed 27 patients, three family members and 10 staff…

Filed under:Practice Support Tagged with:communicationmedical errorspatient communicationphysician-patient communication

Frustrated by Congress, Trump Signs Order to Weaken Obamacare

Yasmeen Abutaleb and Jeff Mason  |  October 12, 2017

WASHINGTON (Reuters)—President Donald Trump on Thursday signed an order to make it easier for Americans to buy bare-bones health insurance plans, using his presidential powers to undermine Obamacare after fellow Republicans in Congress failed to repeal the 2010 law. Trump issued the executive order aimed at letting small businesses band together across state lines to…

Filed under:Legislation & Advocacy Tagged with:executive orderObamacare

Secukinumab Meets 5-Year Benchmark for Psoriasis

Michele B. Kaufman, PharmD, BCGP  |  October 6, 2017

In an extension study, nearly half the patients with plaque psoriasis taking secukinumab maintained skin clearance for the five years of the study…

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsPsoriatic Arthritis Tagged with:Ankylosing SpondylitisPsoriasisPsoriatic Arthritissecukinumab

What Price Glory (or, at Least, Getting Your Foot in the Door)?

Gerald Eisenberg  |  October 4, 2017

In many respects, this is the beginning of the golden age of rheumatology. Diagnostic and therapeutic approaches are now available that have radically altered for the better the lives of people with diseases that were considered virtually untreatable just a few years ago. The rheumatologist’s approach to patients with rheumatoid arthritis, the spondyloarthropathies, osteoporosis and…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Capitol HillIllinois Bone and Joint Institute (IBJI)RheumPACRheumPAC donors

Obamacare Sign-Up Challenge: Proving the Law Is Not Dead

Yasmeen Abutaleb  |  October 4, 2017

NOGALES, Arizona (Reuters)—More than two thousand miles away from the healthcare debate in Washington, President Donald Trump’s threats to let Obamacare collapse are sowing confusion about its fate and dampening 2018 enrollment expectations. The uncertainty here in Arizona, echoed in interviews across the country, shows that even though they have not been able to repeal…

Filed under:Legislation & Advocacy Tagged with:Affordable Care Act (ACA)Obamacare collapse

Efficacy Studied Following Accelerated Drug Approvals

Michele B. Kaufman, PharmD, BCGP  |  October 2, 2017

In recent years, the number of drugs to receive accelerated FDA approval has increased. A new study examined whether these drugs have demonstrated efficacy in post-approval trials…

Filed under:Drug Updates Tagged with:acceleratedFDAFDA approvalU.S. Food and Drug Administration (FDA)

Adalimumab + Methotrexate Effective for Uveitis in JIA

Lara C. Pullen, PhD  |  October 2, 2017

Research has found that taking adalimumab plus methotrexate is effective for patients with juvenile idiopathic arthritis-associated uveitis. However, these patients may also experience an increased incidence of adverse and serious adverse events compared with those taking only methotrexate…

Filed under:ConditionsOther Rheumatic ConditionsPediatric Conditions Tagged with:adalimumabJIAJuvenile Arthritis (JIA)MethotrexatePediatricPediatric RheumatologyUveitis

Help Pediatric Patients Overcome Pain & Anxiety

Karen Appold  |  September 29, 2017

Pediatric rheumatology patients present unique challenges. According to Kyla Driest, MD, MEd, using age and temperament appropriate methods, such as distraction or icing, may help children manage pain and ease anxiety…

Filed under:ConditionsPediatric ConditionsPractice Support Tagged with:Childrenpatient carepatient communicationPediatricPediatric Rheumatology

Sequential Therapy May Reduce Hip Fracture Risk; Plus New Biosimilar Available in Canada

Michele B. Kaufman, PharmD, BCGP  |  September 27, 2017

Patients who receive abaloparatide and switch to alendronate have a statistically significant reduction in fracture risk through 3.5 years, according to a new study…

Filed under:Biologics/DMARDsDrug Updates Tagged with:abaloparatidealendronateBiologics & Biosimilarsetanerceptetanercept-szzsFractureshiphip fracturehip fracture risk

AMP RA/Lupus Network Shares Its Progress

Lara C. Pullen, PhD  |  September 26, 2017

Researchers from the AMP RA/Lupus Network came together in June at the annual FOCIS meeting to share their progress as they perform a systematic molecular deconstruction of human diseases…

Filed under:ConditionsRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Accelerating Medicines PartnershipLupusNational Institutes of Health (NIH)Rheumatoid Arthritis (RA)systemic lupus erythematosus (SLE)

  • « Previous Page
  • 1
  • …
  • 174
  • 175
  • 176
  • 177
  • 178
  • …
  • 326
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences